Sensor performance, including sensitivity, limit of detection, and specificity, was evaluated by monitoring changes in insertion loss, demonstrating significant potential for clinical applications in real-time PSA detection and prostate cancer diagnosis. This evidence concerns the gene KLK3 and prostate carcinoma.